Revenue from contracts with customers

9 Months Ended

Sep. 30, 2024

Revenue from Contract with Customer [Abstract]

Revenue from contracts with customers

Note 4 – Revenue from contracts with customers

Disaggregated revenue

The Company provided diagnostic test products and laboratory services to hospitals, clinical laboratories and other healthcare providing customers, and entered into collaboration agreements with government agencies, non-governmental organizations, and healthcare providers. The revenues by type of service consist of the following:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2024		2023		2024		2023
Product sales	$	-	$	558,965	$	169,373	$	1,409,534
Laboratory services		-		47,135		26,776		112,810
Collaboration revenue		-		92,922		-		826,257
Total revenue	$	-	$	699,022	$	196,149	$	2,348,601

Revenues by geography are as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2024		2023		2024		2023
Domestic	$	-	$	142,716	$	196,149	$	523,978
International		-		556,306		-		1,824,623
Total revenue	$	-	$	699,022	$	196,149	$	2,348,601

Deferred revenue

Changes to deferred revenue for the periods were as follows:

Balance at December 31, 2022	$	142,061
Contracts with customers		74,109
Recognized in the current period		(144,196	)
Currency translation adjustment		(46,048	)
Balance at December 31, 2023		25,926
Recognized in the current period		(21,096	)
Refunded to customers in the current period		(4,830	)
Balance at September 30, 2024	$	-